Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
25.00
Ask:
28.00
Spread: 3.00 (12.00%)
Market Cap: £12.62m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Covid-19 Update

25 Mar 2020 07:00

RNS Number : 5156H
Pennant International Group PLC
25 March 2020
 

 

FOR IMMEDIATE RELEASE 25 March 2020

PENNANT INTERNATIONAL GROUP PLC

 

Covid-19 Update

 

Pennant International Group plc ("Pennant", the "Group", or the "Company"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, issues the following Covid-19 update.

Current Risks

The Group continues to assess and manage the impact of Covid-19 on its business. Three key risks to trading and prospects have been identified so far.

The first is the challenge of holding review events with customers. Such review events are held, as physical meetings, through the lifecycle of an engineering programme and frequently have milestone payments attached (paid by the customer to Pennant upon successful completion of the review). If the review cannot be held due to Covid-19 restrictions, cash and revenue associated with completion of the milestone may be delayed.

The second risk is the inability to gain access to customer facilities to deliver services. Our 'integrated logistics support' consultancy services are typically delivered at a customer's site; if we cannot access the relevant site due to Covid-19 restrictions, the ability to deliver the services is severely hampered.

Lastly, there is the broader risk that governments and major OEMs which award contracts to Pennant are, in the shorter term at least, consumed by their own efforts to deal with Covid-19 and therefore expected contract awards are consequently delayed until the pandemic has abated.

Actions Taken

With the first two risks set out above, we are working closely with the applicable customers to establish solutions so that reviews and services can be held and provided via remote means. We are confident that workarounds will be possible (and in some cases, these are already being implemented) but the impact on the timing and amount of any affected revenues is not yet clear. The third, macro risk is less easy for Pennant to directly influence, but we remain in close contact with key stakeholders to ensure we are well-informed and remain well-placed for awards.

Simultaneously, we are prioritising the safety and well-being of our employees and other stakeholders and have implemented near-total homeworking already.

Financial Position

We are actively focused on cash and cost management across the business and retain undrawn facilities.

We welcome certain UK Government initiatives to support businesses in these exceptional times, and we have already utilised the UK Government's Coronavirus Job Retention Scheme to protect (and part-fund) the jobs of those employees who are currently unable to carry out their usual duties due to Covid-19 interruption.

We are also investigating other potential financial options, including the Coronavirus Business Interruption Loan Scheme, with a view to securing access to further funding should it be required.

Outlook

With the UK Government's unprecedented restrictions on travel, social and business contact, providing forward guidance is extremely difficult but the Board will be keeping the situation under very close review. The Company intends to announce preliminary results for the year ended 31 December 2019 on Monday 20 April 2020 and will provide a further update at that point.

The Board is confident that the Group's underlying strengths - our long-term customer relationships with governments and major OEMs, contracted order book, specialist services and our quality-assured reputation - will continue to provide a solid foundation for our long-term success.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

 

+44 (0) 1452 714 914

David Clements, Commercial & Risk Director

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Chris Savidge

+44 (0) 117 945 3470

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFIFSRVLIEFII
Date   Source Headline
19th Aug 201611:38 amRNSHolding(s) in Company
16th Aug 20164:38 pmRNSHolding(s) in Company
15th Aug 20168:20 amRNSDirector/PDMR Shareholding
15th Aug 20167:00 amRNSPlacing of £3.56m
19th Jul 20167:00 amRNSRecord Order Book drives expansion of premises
15th Jul 20169:30 amRNSHoldings in Company
14th Jul 201610:55 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSDirector Dealing
20th Jun 201612:05 pmRNSGrant of Options
16th Jun 20167:00 amRNSNew Contract Award and Trading Update
1st Jun 20167:14 amRNSNew Contract Awards worth in excess of £13 million
18th May 201612:00 pmRNSDirectorate Change
20th Apr 201611:17 amRNSResult of AGM and GM
19th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20167:00 amRNSDocuments available on the Company's website
7th Mar 20167:00 amRNS2015 Final Results
3rd Mar 201611:00 amRNSDirectorate Change
5th Feb 20167:00 amRNSNew Contract Award & Notice of 2015 Final Results
11th Dec 20157:00 amRNSTrading Update
17th Nov 20157:00 amRNSDirectorate Change
19th Oct 20151:40 pmRNSDirector/PDMR Shareholding
5th Oct 20157:00 amRNSDirector Incentivisation
28th Sep 20157:00 amRNSNew £7million Contract Award
28th Sep 20157:00 amRNS2015 Interim Results
18th Sep 201512:00 pmRNSNotice of Results
26th Aug 20152:47 pmRNSHolding(s) in Company
14th Apr 201511:12 amRNSResult of AGM and GM
8th Apr 20152:30 pmRNSDirector/PDMR Shareholding
17th Mar 201512:00 pmRNSDocuments available on the Company's website
17th Mar 20159:55 amRNSDocuments available on the Company's website
17th Mar 20157:00 amRNS2014 Final Results
6th Mar 20157:00 amRNSNotice of Final Results
22nd Jan 20157:00 amRNSPre-close Trading Update
10th Nov 201412:00 pmRNSTransaction in Own Shares
22nd Sep 20147:00 amRNSDirectorate Change
17th Sep 20147:00 amRNSContract win
8th Sep 20147:00 amRNSHalf Yearly Report
1st Sep 201411:35 amRNSNotice of Results
15th Jul 20144:29 pmRNSDirector/PDMR Shareholding
24th Jun 20144:36 pmRNSDirector Dealing
6th Jun 20145:17 pmRNSDirector/PDMR Shareholding
29th Apr 20144:20 pmRNSDirector Incentivisation
10th Apr 20143:39 pmRNSResult of Meeting
12th Mar 20147:00 amRNSDirectorate Change
10th Mar 20147:00 amRNSFinal Results
10th Feb 20143:45 pmRNSHolding(s) in Company
3rd Feb 20142:14 pmRNSHolding(s) in Company
3rd Feb 20142:00 pmRNSHolding(s) in Company
9th Dec 20134:15 pmRNSHolding(s) in Company
14th Nov 201311:10 amRNSNotification of Major Interest of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.